Search Contract Opportunities

Celecoxib   3

ID: SPE2D2-20-R-0075 • Type: Solicitation • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this contract have any security clearance requirements?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: June 5, 2025, 10:15 a.m. EDT

Modification to announce exercising 3rd option year.

Posted: Aug. 1, 2024, 10:55 a.m. EDT
Posted: Nov. 12, 2020, 11:08 a.m. EST
Posted: Nov. 9, 2020, 10:04 a.m. EST
Posted: Oct. 28, 2020, 11:15 a.m. EDT
Posted: Oct. 1, 2020, 1:55 p.m. EDT
Background
The contract is issued by DLA Troop Support, specifically the Medical Supply Chain, located in Philadelphia, PA. The agency's mission is to provide logistics support for the military and other federal agencies. This modification serves to announce the exercising of the third option year for the contract related to CELECOXIB.

Work Details
The contract involves the procurement of CELECOXIB, a medication used for pain relief and inflammation. The amendment indicates that the solicitation number SPE2D220R0075 has been modified, with changes to the opening and closing dates of offers. The new closing date is set for November 23, 2020, at 3:00 PM EDT.

Period of Performance
The period of performance includes an option year that has been exercised; however, specific dates beyond the amendment date are not detailed.

Place of Performance
The place of performance is not explicitly stated in the provided text but typically would be at locations designated by DLA Troop Support.

Overview

Agency
DLA Troop Support - Medical [DoD - DLA]
Response Deadline
Nov. 2, 2020, 3:00 p.m. EST Past Due
Posted
Oct. 1, 2020, 1:55 p.m. EDT (updated: June 5, 2025, 10:15 a.m. EDT)
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 10/1/20 DLA Troop Support - Medical issued Solicitation SPE2D2-20-R-0075 for Celecoxib due 11/2/20. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Ryan Guarnere   Profile
Email
ryan.guarnere@dla.mil
Phone
(215) 737-3182

Secondary Contact

Name
Jason Wray   Profile
Email
jason.wray@dla.mil
Phone
(215) 737-0614

Documents

Posted documents for Solicitation SPE2D2-20-R-0075

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2D2-20-R-0075

Award Notifications

Agency published notification of awards for Solicitation SPE2D2-20-R-0075

IDV Awards

Indefinite delivery vehicles awarded through Solicitation SPE2D2-20-R-0075

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2D2-20-R-0075

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2D2-20-R-0075

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
June 5, 2025
Last Updated By
ryan.guarnere@dla.mil
Archive Date
Nov. 2, 2026